
Combovir tablets contain the antiviral medicines nirmatrelvir 150 mg and ritonavir 100 mg. This combination is used for the early treatment of mild-to-moderate COVID-19 in selected patients who may be more likely to develop severe disease. It is a prescription medicine and is not intended for routine COVID-19 prevention.
| Generic Name | Nirmatrelvir/Ritonavir |
| Manufacturer | Bruck Pharma Private Limited |
| Packing | 10 + 20 Tablets |
| Prescribed For | COVID-19 |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Nirmatrelvir stops the coronavirus from processing proteins needed to create new virus particles. Ritonavir works as a pharmacokinetic enhancer, slowing the removal of nirmatrelvir so that sufficient medicine remains available in the body.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.